A vs COLL
Agilent Technologies Inc (A) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
A currently screens at market cap $33.70B and trailing P/E 29.2. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the A and COLL stock pages for the full models.
Not investment advice.